|Mr. Kevin A. Lobo||Chairman and Chief Exec. Officer||3.74M||N/A||52|
|Mr. Glenn S. Boehnlein||Chief Financial Officer and VP||1.15M||N/A||55|
|Mr. Timothy J. Scannell||Group Pres of MedSurg & Neurotechnology||1.53M||6.96M||52|
|Mr. Lonny J. Carpenter||Group Pres of Global Quality and Bus. Operations||1.16M||864k||55|
|Mr. David K. Floyd||Group Pres of Orthopaedics||1.3M||N/A||56|
Stryker Corporation, together with its subsidiaries, operates as a medical technology company. It operates through three segments: Orthopaedics; MedSurg; and Neurotechnology and Spine. The Orthopaedics segment offers implants for use in hip and knee joint replacements, and trauma and extremities surgeries. The MedSurg segment provides surgical equipment and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, and reprocessed and remanufactured medical devices, as well as other medical devices for use in various medical specialties. The Neurotechnology and Spine segment offers neurosurgical and neurovascular devices that include products used for minimally invasive endovascular techniques; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, including synthetic bone grafts and vertebral augmentation products; and minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke. This segment also provides spinal implant products, which consists of cervical, thoracolumbar, and interbody systems for use in spinal injury, deformity, and degenerative therapies. The company markets and sells its products to doctors, hospitals, and other healthcare facilities through company-owned sales subsidiaries and branches, as well as third-party dealers and distributors in approximately 100 countries. Stryker Corporation was founded in 1941 and is headquartered in Kalamazoo, Michigan.
Stryker Corporation’s ISS Governance QualityScore as of May 1, 2017 is 2. The pillar scores are Audit: 1; Board: 7; Shareholder Rights: 2; Compensation: 5.